Stuart Paynter

Stuart Paynter

Director of Finance/CFO at OXFORD BIOMEDICA PLC

Net worth: 47 449 $ as of 2024-03-30

52 year
Health Technology
Commercial Services
Consumer Services

Profile

Stuart Paynter is currently the Chief Financial Officer & Director at Oxford Biomedica Plc, as well as a Director at Oxxon Therapeutics Ltd.
and a Member of the Institute of Chartered Accountants in England & Wales.
He previously worked as the Finance Director-European Region at STERIS Ltd.
from 2001 to 2007, Senior Director-Finance Business at Shire Pharmaceuticals Ltd.
from 2007 to 2016, and Head-Finance Business Partnering at De La Rue Plc from 2016 to 2021.
He received his undergraduate degree from Imperial College London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-09-19 18,687 ( 0.02% ) 47 449 $ 2024-03-30

Stuart Paynter active positions

CompaniesPositionStart
OXFORD BIOMEDICA PLC Director of Finance/CFO 2017-08-28
Corporate Officer/Principal -
Director/Board Member -
Director/Board Member 2017-08-28
All active positions of Stuart Paynter

Former positions of Stuart Paynter

CompaniesPositionEnd
DE LA RUE PLC Corporate Officer/Principal 2021-06-30
Director of Finance/CFO 2016-01-31
Corporate Officer/Principal 2007-06-30
See the detail of Stuart Paynter's experience

Training of Stuart Paynter

Imperial College London Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stuart Paynter's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
DE LA RUE PLC

Commercial Services

OXFORD BIOMEDICA PLC

Health Technology

Private companies5

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Stuart Paynter